---

In a strategic move, the NABH accredited Ayurveda hospital network, Apollo AyurVAID has announced its foray into Ayurvedic product segment, taking its expansion beyond clinical care.

Apollo AyurVAID's product range features clinically proven formulations that are certified safe by NABL-accredited laboratories for presence of heavy metals, aflatoxins, microbial content, etc.

The new portfolio will include classical formulations, OTC products and medical foods. Classical formulations will be available through prescription while the OTC and medical foods lines will be supplied through a wide network of retail and digital platforms. The OTC range features innovative medicine formats such as creams, transdermal pads, essential extracts, etc., for special customer segments (women, child, elder, etc.) and applications (pain, sleep, stress, skin etc.).

India’s Ayurvedic products market is worth Rs 60,000 crore and is growing at over 16 per cent annually.

Rajiv Vasudevan, Founder, MD, and CEO, Apollo AyurVAID anticipates the portfolio to be a key growth driver and to generate a revenue of Rs 500 crore in the next five years. According to him the new vertical not only complements its inpatient-outpatient care model but also opens scalable revenue opportunities and reinforces its vision of mainstreaming evidence-based Ayurveda services and products by making it accessible globally.

AyurVAID plans to expand its hospital network by adding 9 new points of presence, raising the bed capacity to 350, aiming to treat over 50,000 patients, in the current year. The company expects to surpass the annualised Rs. 100 crore revenue mark by mid next year.

Founded in 2005, it has been a part of the Apollo group since 2022. Dr. Preetha Reddy, Executive Vice Chairperson, Apollo Hospitals and Chairperson, Apollo AyurVAID said Apollo AyurVAID's foray into tested-safe Ayurveda products marks a pivotal step in redefining standards of safety, transparency, and efficacy in traditional medicine.

Apollo AyurVAID has recently partnered with integrated systems biology platform company, Avesthagen Limited, to co-develop and offer scientifically validated, botanical-actives based dietary supplements which will be followed with an Ayurveda based medical foods range for specific clinical indications.

---

Related Articles

WHO announces four new goodwill ambassadors for promoting global health

Rheumatoid Arthritis: Ayurveda to be scientifically compared with modern medicine in efficacy

Experts call for India, UK tie-up to promote Ayurveda

Uttarakhand woos investors to spruce up Wellness sector

‘Ayurveda, Yoga benefits go beyond Wellness’

Ayurveda: India for enhancing global co-operation